Publications by authors named "B Zegels"

Claim this Profile
C
Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria.
O Bruyère, M Fossi, B Zegels, L Leonori, M Hiligsmann

Rheumatol Int· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX) to assess the 10-year probability of fracture.
O Bruyère, D Nicolet, S Compère, V Rabenda, P Jeholet, B Zegels

Rheumatol Int· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study.
B Zegels, P Crozes, D Uebelhart, O Bruyère, J Y Reginster

Osteoarthritis Cartilage· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study.
O Bruyère, O Ethgen, A Neuprez, B Zégels, Ph Gillet

Arch Orthop Trauma Surg· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of collagen hydrolysate in articular pain: a 6-month randomized, double-blind, placebo controlled study.
O Bruyère, B Zegels, L Leonori, V Rabenda, A Janssen

Complement Ther Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis